Printer Friendly

Articles from The Fly (August 5, 2019)

1-222 out of 222 article(s)
Title Author Type Words to acquire Shari's Berries, other assets of FTD for $20.5M. 151
Abiomed says CMS eliminated proposed 27% reduction for IPPS. 145
Acceleron reports Q2 EPS (34c), consensus (30c). Financial report 159
Acco Brands acquires Industria Grafica Foroni for $57M. 112
AcelRx sees R&D and SG&A expense for the rest of the year $16M-$18M. 188
Action Report: Big July Gains for U.S. Treasury Receipts. Report 120
Aimmune FDA panel could break downward share trend, says Piper Jaffray. 102
Air Transport Services backs FY19 adjusted EBITDA view $450M. 320
Akebia announces settlement of Auryxia patent litigation with Par Pharmaceutical. 180
Allakos reports Q2 EPS (44c), consensus (45c). Financial report 138
Allakos says AK002 met all primary, secondary endpoints in Phase 2 study. 553
Alnylam granted FDA priority review for Givosiran NDA in AHP. 147
American Equity reports Q2 adjusted EPS $1.09, consensus 95c. Financial report 127
American Resources files updated bid to purchase certain Blackjewel properties. 318
Amneal Pharmaceuticals co-founders return as Co-CEOs. 181
Amplify Energy expects Midstates Petroleum merger to close on August 6. 198
Applied DNA Sciences, TheraCann sign term sheet to amend licensing agreement. 116
Arbutus Biopharma expects cash, investments balance to fund operations in 2H20. 116
Arbutus Biopharma expects results from Phase 1a/1b trial of AB-506 in 1H20. 138
Arbutus expects preliminary data from Phase 1a/1b trial of AB-729 in 1Q20. 115
Arch Therapeutics says AC5 platform shows antimicrobial activity in two studies. 425
Arvinas reports Q2 EPS (55c), consensus (40c). Financial report 174
Ashford Hospitality selling Marriott Plaza San Antonio for $34M. 140
Asian Market Wrap:. 234
Assembly Biosciences reports Q2 EPS (72c), consensus ($1.15). Financial report 103
Astronics sees 2019 revenue $740M-$775M, consensus $783.29M. 135
Athene Holding reports Q2 adj. EPS $1.95, consensus $1.82. Financial report 190
Aytu BioScience: ZolpiMist results show more rapid sleep onset with Zolpidem. 252
BAE Systems, Booz Allen, CACI and Leidos awarded on combined $17.1B contract. 183
Beasley Broadcast CEO says committed to improving top-, bottom-line performance. 122
Beasley Broadcast expects WDMK-FM acquisition to be immediately accretive to FCF. 308
Beasley Broadcast reports Q2 EPS 15c, two est. 15c. Financial report 158
BioCryst reports inducement grants under Nasdaq listing rule. 149
Biofrontera says 'able to seamlessly integrate' Cutanea into organization. 363
BioScrip not the acquirer in merger, which is positive, says Lake Street. 114
Black Hills reports Q2 EPS 24c, consensus 44c. Financial report 185
Blueknight Energy Partners receives buyout offer from Ergon. 182
Boise Cascade reports Q2 EPS 71c, may not compare to consensus 48c. Financial report 130
Boise Cascade sees slower demand for products in FY19. 469
Bombardier, Orascom, Arab Contractors win monorail line contract. 244
Brighthouse Financial reports Q2 adjusted EPS $2.19, consensus $2.26. Financial report 103
Cabot not seeing stronger auto production yet, sees FY19 EPS in line with FY18. 126
Cabot reports Q3 adjusted EPS $1.00, consensus $1.00. Financial report 115
Caesars CEO says 'delivered solid financial results' in Q2. Financial report 145
Camber Energy unit awarded $3.9M pipeline repair project. 141
Capital Southwest reports Q1 NII 42c, consensus 40c. 160
Capitala Finance reports Q2 NII 25c, consensus 24c. 134 CEO says seeing 'continued reductions in OEM advertising'. 113 completes strategic review, will remain independent public company. 153 reports Q2 average monthly unique visitors of 21.6M, up 13% y/y. 111
Celsion announces data lock for interim analysis in OPTIMA Phase III study. 373
Centennial Resource Development reports Q2 EPS 7c, consensus 11c. Financial report 151 reports Q2 EPS 27c, consensus 49c. Financial report 152
Chanticleer Holdings' Little Big Burger launches loyalty program. 183
Chart Industries announces strategic investment in Stabilis Energy of up to $7M. 208
Chemed raises FY19 adj. EPS view to $13.65-$13.85 from $12.65-$12.85. 117
Chemed subsidiary acquires assets of independent franchise operator for $120M. 132
Cohu reports Q2 EPS 2c, consensus 1c. Financial report 108
Community Health reports Q2 adjusted EPS (47c), consensus (51c). Financial report 117
Concho Resources valuation could be 'approaching a floor,' says JPMorgan. 101
Continental Resources raises FY19 oil production view to 195,000-200,000 Bopd. 267
Crawford & Company reports Q2 EPS 19c, consensus 20c. Financial report 146
Daseke announces new strategic integration, efficiency program. 220
Daseke expects annual savings of $10M in improved operating income in 2020. 161
DD3 Acquisition Corp enters into definitive merger agreement with Betterware. 179
Delek US acquires 15% interest in Wink to Webster Pipeline. 145
Deutsche Bank upgrades Target to Buy, boosts price target to $99 from $85. 152
Diamond Offshore reports Q2 adj. EPS (99c), consensus (88c). Financial report 133
DiamondRock rises FY19 AFFO $1.01-$1.05 from $1.00-$1.04. 118
Digital Ally announces partnership with KMC Brands. 199
Diodes sees Q3 revenue $324M, plus or minus 2%, consensus $328.15M. Financial report 169
Dropbox's latest moves improve risk/reward profile, says William Blair. 120
Dynamex enters into definitive merger agreement with Betterware. 179
Eagle Pharmaceuticals announces breast cancer product development plan. 165
Eli Lilly CONQUER study of Emgality meets primary, secondary outcomes. 430
Ellington Financial reports Q2 core EPS 46c, consensus 42c. Financial report 130
Eloxx Pharmaceuticals initiates Phase 2 clinical trial for ELX-02. 199
Emerson a good value after 'unwarranted' pullback, says Stephens. 114
Enphase Energy program for early adopters reaches over 5,300 homeowners. 138
Enzo Biochem issued patent for nucleic acid hybridization probe technology. 103
Evofem reports additional data from Phase 3 'AMPOWER' study of Amphora. 152
Falcon Minerals reports Q2 EPS 8c, consensus 12c. Financial report 186
FDA posts briefing ahead of meeting to discuss sNDA for Gilead's Descovy. 216
Fed funds futures have a solid bid amid flight to safety. 105
Fed unveils plans for 'round-the-clock real-time' payment systems. 162
Finisar announces departure of CEO Michael Hurlston. 163
Fly Intel: Pre-market Movers. Clinical report 200
Fly Intel: Top five analyst downgrades. 174
Fly Intel: Top five analyst upgrades. 210
Foamix submits NDA to FDA for FMX103. 149
Forterra reports Q2 EPS 5c, consensus 9c. Financial report 171
Forterra sees FY19 adjusted EBITDA 170M to $200M. 117
Fossil launches smartwatch capabilities within Wear OS by Google platform. 188
FuelCell announces 9M MWH of clean power generation. 121
FX Update: The dollar has been trading mixed. 189
FX Update: The dollar has been trading mixed. 227
Gains to long VIX calls opened two weeks ago near $100M. 127
Galectin Therapeutics submits Phase 3 NASH-RX protocol to FDA. 280
Game stocks slide as Trump blames video games as contributors to mass shootings. 377
Gannett names Paul Bascobert president, CEO. 104
Genentech says Phase III IMvigor130 study met co-primary endpoint. 201
Genesee & Wyoming enters into divestiture agreement. 130
GenMark reports Q2 EPS (23c), consensus (21c). Financial report 149
Gol Linhas reports preliminary July domestic supply results down 0.8%. Financial report 108
Google worker claims discrimination against pregnant women, Motherboard says. 227
Green Plains signs LOI to sell at least 50% of cattle unit to investors. 376
Guardant Health says study finds Guardant360 MSI highly concordant to tissue. Clinical report 286
Guggenheim questions Square's 'uniqueness' after Caviar sale. 169
H.C. Wainwright reiterates Buy on DBV ahead of expected BLA resubmission. 122
Health Insurance Innovations reports Q2 EPS 71c, consensus 40c. Financial report 139
HighPoint Resources reports Q2 EPS (7c), consensus (5c). Financial report 189
HSBC names Noel Quinn interim CEO, John Flint to step down as CEO. 212
HSBC says does not expect to achieve 6% RoTE target in the U.S. by 2020. 137
IBM guidance with Red Hat in-line with Morgan Stanley expectations. 124
iClick Interactive Asia signs MOU for business partnership with Vector. 208
IFF reports Q2 adjusted EPS ex-amortization $1.61, consensus $1.62. Financial report 270
INmune Bio reports preliminary data from INB103 Phase 1 clinical trial. 291
Intel, Lenovo announce HPC and AI convergence collaboration. 140
Inter Parfums reports Q2 EPS 39c, consensus 37c. Financial report 130
IntercontinentalExchange to acquire MOVE family of indices. 144
Intra-Cellular agrees to submit additional info for NDA review of lumateperone. 199
Intrexon's Precigen doses first patient in Phase 1 study of PRGN-3005. 141
iPic Entertainment initiates proceedings under Chapter 11. 361
Jacobs Engineering reports Q3 adj. EPS $1.40, consensus $1.24. 114
Jupiter Gold receives mining license for Paracatu gold project. 107
Just Energy announces departure of president, CEO Patrick McCullough. 138
Kadmon reports Q2 EPS 7c, consensus (16c). Financial report 149
Kennametal sees FY20 EPS $2.80-$3.20, consensus $3.21. 229
Kiniksa announces collaboration with the Myocarditis Foundation. 224
KKR bid for Axel Springer wins shareholder approval. 199
Kosmos reports Q2 adj. EPS 5c, consensus 5c. Financial report 102
Krystal Biotech expects to start Phase 3 clinical trial for KB103 in Q4. 176
Krystal Biotech reports Q2 EPS (37c), consensus (32c). Financial report 121
Kuo: iPhone prices won't go higher amid China trade war, CNBC reports. 113
Linde plc reports Q2 adjusted EPS $1.83, consensus $1.73. Financial report 120
Lonestar reports Q2 adjusted EPS (2c), consensus (4c). Financial report 125
Lonestar Resources sees FY19 production 13.7K-14.7K BOE/d. 235
Louisiana loss a 'surprising negative' for Centene, says Wells Fargo. 115
Louisiana to contract with four managed care companies for Medicaid enrollees. 130
MannKind, One Drop sign collaboration agreement for BluHale integration. 128
Marimed launches Hemp Engine marketing platform for CBD sector. 153
Marriott CEO says Q2 results 'highlight the resiliency of our business model'. 228
Masonite CEO says markets remain softer than anticipated. 125
Medallion Financial reports Q2 EPS (31c), consensus 11c. Financial report 182
Middlesex Water concludes common stock 5% discount purchase program. 130
Mimecast sees FY19 revenue $414M-$422.6M , consensus $420.31M. 113
Minerva expects to complete enrollment for Phase 2b trial of MIN-117 in Q3. 117
Mistras reports Q2 EPS 22c, consensus 18c. Financial report 114
Mueller Water sees FY19 adjusted EBITDA up 12%-15% vs last year. 122
Mustang Bio receives FDA approval for MB-102 IND. 162
NanoViricides' first drug candidate on track with GLP safety studies. 193
Natera's Panorama test shows 100% accuracy in identical twin detection. Clinical report 101
National CineMedia reports Q2 EPS 11c, consensus 10c. Financial report 103
NCS Multistage reports Q2 EPS (11c), consensus (20c). Financial report 270
New Media to acquire Gannett for consideration of $12.06 per Gannett share. 434
New York Mortgage reports Q2 EPS 18c, consensus 16c. Financial report 117
Novavax reaches agreement with FDA on Phase 3 trial design for NanoFlu. 113
Nuance announces name, brand identity for automotive spin-off. 123
October calls see heavy volume in Marathon Petroleum. 116
OFS Credit announces commencement of rights offering. 139
Oracle Health Sciences, HCL Technologies collaborate to accelerate mHealth. 120
Orion Energy backs FY20 revenue view $135M-$145M, consensus $139.89M. 114
Orion Energy reports Q1 EPS 13c, consensus 2c. Financial report 401
Orion Engineered cut to Hold at Loop Capital on deteriorating fundamentals. 106
Orthofix names Jon Serbousek successor to CEO Brad Mason. 151
Otter Tail reports Q2 EPS 39c, two estimates 45c. Financial report 119
Park-Ohio backs FY19 adjusted EPS view $4.30-$4.60, consensus $4.40. 108
Patterson-UTI reports an average of 150 drilling rigs operating in July. 111
Penn National is 'underappreciated and oversold,' says Barclays. 102
Progenics completes enrollment in Phase 3 CONDOR study of PYL. 220
PTC Therapeutics signs long-term lease agreement with Bristol-Myers in NJ. 138
Radius Health announces initiation of Phase 3 wearABLe study. 297
RegeneRx announces enrollment of first patient in RGN-137 trial. 262
Renault, Nissan hope to reshape alliance, restart Fiat Chrysler talks, WSJ says. 105
Revance reports Q2 EPS (86c), consensus (91c). Financial report 140
RLH provides update on expectations for asset sales. 457
Ryerson sees Q3 EPS 66c-77c, consensus 45c. 153
Safehold signs agreements for $600M of ground leases. 182
Sapiens reports Q2 EPS 19c, consensus 17c. Financial report 141
Seacor acquires JV's interest in Sea-Vista for $106M in cash and stock. 227
Senators ask Google to covert temporary workers to full-time, NY Times reports. 118
Shake Shack announces Grubhub as its national delivery partner. 168
Shake Shack raises 2019 revenue outlook to $585M-$590M from $576M-$582M. 166
Shake Shack reports Q2 EPS 29c, consensus 23c. Financial report 163
Sienna Biopharmaceuticals engages Cowen to explore strategic alternatives. 109 reports Q2 EPS ($1.27), consensus ($1.14). Financial report 237
Solar Capital reports Q3 EPS 46c, consensus 44c. Financial report 130
Spirit MTA REIT files materials for $2.4B asset sale to Hospitality Properties. 105
Stifel sees multiple paths to outsized returns with Circor, upgrades to Buy. 133
SurveyMonkey to acquire GetFeedback for approximately $68M. 102
Synchronoss reports Q2 EPS (28cc), consensus (47c). Financial report 214
Take-Two reports Q1 GAAP EPS 41c, consensus 2c. Financial report 189
Taronis Technologies announces MOU with Latin American fuels distributor. 182
Textron reviewing strategic alternatives for Kautex. 177
The U.S. July ISM-NMI drop to a 3-year low of 53.7. 170
TravelCenters reports Q2 adj. EPS 15c, may not compare to consensus 68c. Financial report 228
TravelCenters say five-to-one reverse stock split effective Aug. 1. 107
Treasury Action: supply heats up this week. 148
Treasury Action: the drop in yields has deepened. 109
Treasury Market Outlook: yields are lower globally. 303
Treasury Market Summary. 134
Treasury's $78 B 3- and 6-month bill auctions were mixed. 245
Tyson Foods expects FY20 sales approx. $45B-46B, consensus $45.2B. 497
Tyson Foods reports DOJ subpoena seeking information related to chicken industry. 205
Tyson Foods reports DOJ subpoena seeking information related to chicken industry. 294
Tyson Foods reports Q3 adjusted EPS $1.47, consensus $1.41. 143
U.S. Army awards Lockheed 3 contracts to produce Q-53 radars and capabilities. 191
U.S. equities have plunged. 182
U.S. final Markit services PMI rose 1.5 points to 53.0 in July. 117
U.S. ISM nonmanufacturing index fell another 1.4 points to 53.7 in July. 159
U.S. Treasury designates China as currency manipulator. 139
Univar sees Q3 adj. EBITDA $180M-$190M. 272
Universal Logistics commences 'Dutch auction' to purchase up to 300,000 shares. 107
Valeritas reports preclinical data from PK study of Apo delivered via h-Patch. 361
Veeco reports Q2 EPS (6c), consensus (9c). Financial report 121
VIVUS announces approval of Qsymia in the Republic of Korea. 108
Vystar Corp granted notice of allowance for patent for natural rubber latex. 132
W.R. Grace licenses UNIPOL PP Process Technology to Datong Coal Mine Group. 130
Walmart not planning to stop selling guns, ammo after shooting, Bloomberg says. 125
Week Ahead: Global Threats Manifesting? 112
XPO Logistics price target raised to $81 from $73 at Credit Suisse. 104
Yield10 Bioscience granted U.S. patent covering crop yield trait C3003. 164

Terms of use | Privacy policy | Copyright © 2021 Farlex, Inc. | Feedback | For webmasters